β - Nicotinamide Mononucleotide (NMN)

What is NMN?
β-Niacinamide mononucleotide (NMN), a precursor for nicotinamide adenine dinucleotide (NAD+) (a key player in many cell processes and maintaining our body’s status quo), is currently being investigated in numerous clinical trials and other research to evaluate its use as a supplement to combat a variety of aging-related changes.

In 2018, with the release of the 11th edition of the World Health Organization (WHO)’s ICD codes (International Classification of Diseases), age-related diseases were included as a disease state.

Classifying aging as a disease opened the door to research on various topics related to boosting NAD+ in mammalian cells and the possible benefits of slowing down aging. NAD+ plays a key role in many activities in the body that, with aging, decline. Studies show that NAD+ levels drop almost 50% once we reach middle age.

NMN benefits
Taken by mouth, NMN is quickly and efficiently absorbed and converted into NAD+. Preliminary clinical trials in mice and other lab animals, with a handful of recent studies conducted or ongoing in humans, suggest that enhanced levels of NAD+ suppress age-related fat-causing inflammation in tissues and improve the production and action of insulin, brain function, and more. Additionally, possible benefits of NMN supplementation may include:

- Improved brain health
- NMN’s anti-aging skin benefits (our body’s largest organ)
- Fertility benefits
- Heart protective effects (cardio protective)
- Improved diabetes health & insight into obesity
- Improved sleep